Clover Health Investments Corp. [NASDAQ: CLOV] traded at a low on 09/20/21, posting a -5.54 loss after which it closed the day’ session at $7.85. The company report on September 16, 2021 that Clover Health to Provide In-Home COVID-19 Vaccinations to Medicare Advantage Members.
Partnership with MedArrive will help ensure swift vaccine access and administration for Clover’s homebound and most medically complex members, starting in New Jersey.
, Clover Health (NASDAQ: CLOV) (“Clover”), a technology company committed to improving health equity for America’s seniors, announced that it will provide in-home COVID-19 vaccinations, which is especially critical to support Clover’s medically-complex and homebound members. Clover has partnered with MedArrive, a healthcare logistics and services platform, to kick off the vaccination program in New Jersey.
The results of the trading session contributed to over 21551530 shares changing hands. Over the past one week, the price volatility of Clover Health Investments Corp. stands at 5.41% while the volatility over the past one month is 7.49%.
The market cap for CLOV stock reached $1.95 billion, with 408.16 million shares outstanding and 216.71 million shares in the current float. Compared to the average trading volume of 36.93M shares, CLOV reached a trading volume of 21551530 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Clover Health Investments Corp. [CLOV]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CLOV shares is $9.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CLOV stock is a recommendation set at 3.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Cowen have made an estimate for Clover Health Investments Corp. shares, keeping their opinion on the stock as Underperform, with their previous recommendation back on September 10, 2021. While these analysts kept the previous recommendation, Citigroup raised their target price to Neutral. The new note on the price target was released on September 02, 2021, representing the official price target for Clover Health Investments Corp. stock. Previously, the target price had yet another raise to $9, while JP Morgan analysts kept a Underweight rating on CLOV stock.
The Average True Range (ATR) for Clover Health Investments Corp. is set at 0.66, with the Price to Sales ratio for CLOV stock in the period of the last 12 months amounting to 3.18. The Price to Book ratio for the last quarter was 10.33, with the Price to Cash per share for the same quarter was set at 2.45.
How has CLOV stock performed recently?
Clover Health Investments Corp. [CLOV] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -6.21. With this latest performance, CLOV shares gained by 3.84% in over the last four-week period, additionally sinking by -10.69% over the last 6 months – not to mention a drop of -37.50% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CLOV stock in for the last two-week period is set at 42.42, with the RSI for the last a single of trading hit 38.46, and the three-weeks RSI is set at 44.30 for Clover Health Investments Corp. [CLOV]. The present Moving Average for the last 50 days of trading for this stock 8.46, while it was recorded at 8.15 for the last single week of trading, and 10.24 for the last 200 days.
Clover Health Investments Corp. [CLOV]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Clover Health Investments Corp. [CLOV] shares currently have an operating margin of -5752.28. Clover Health Investments Corp.’s Net Margin is presently recorded at -5752.28.
Return on Total Capital for CLOV is now -1.70, given the latest momentum, and Return on Invested Capital for the company is -1.70. Return on Equity for this stock declined to -1.70, with Return on Assets sitting at -1.57. When it comes to the capital structure of this company, Clover Health Investments Corp. [CLOV] has a Total Debt to Total Equity ratio set at 0.10. Additionally, CLOV Total Debt to Total Capital is recorded at 0.10, with Total Debt to Total Assets ending up at 0.09.
Reflecting on the efficiency of the workforce at the company, Clover Health Investments Corp. [CLOV] managed to generate an average of -$14,727 per employee.Clover Health Investments Corp.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.70 and a Current Ratio set at 3.70.
Earnings analysis for Clover Health Investments Corp. [CLOV]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CLOV. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Clover Health Investments Corp. go to 18.00%.
Insider trade positions for Clover Health Investments Corp. [CLOV]
There are presently around $1,082 million, or 54.80% of CLOV stock, in the hands of institutional investors. The top three institutional holders of CLOV stocks are: GREENOAKS CAPITAL PARTNERS LLC with ownership of 96,331,338, which is approximately 0% of the company’s market cap and around 0.20% of the total institutional ownership; VANGUARD GROUP INC, holding 9,529,811 shares of the stock with an approximate value of $74.81 million in CLOV stocks shares; and BAILLIE GIFFORD & CO, currently with $40.37 million in CLOV stock with ownership of nearly 0% of the company’s market capitalization.
Positions in Clover Health Investments Corp. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 86 institutional holders increased their position in Clover Health Investments Corp. [NASDAQ:CLOV] by around 7,604,620 shares. Additionally, 82 investors decreased positions by around 25,709,188 shares, while 24 investors held positions by with 104,533,260 shares. The mentioned changes placed institutional holdings at 137,847,068 shares, according to the latest SEC report filing. CLOV stock had 57 new institutional investments in for a total of 3,826,540 shares, while 49 institutional investors sold positions of 7,162,803 shares during the same period.